PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.\', \'School of Medicine, Tsinghua University, Beijing, China.\', \'University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA, USA.\', \'Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.\', \'Biomedical Sciences, Infectious and Immunologic Diseases Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.\', \'Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.\', \'Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA, USA.\', \'Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.\', \'Division of Cardiology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15252/msb.202110239
?:hasPublicationType
?:journal
  • Molecular systems biology
is ?:pmid of
?:pmid
?:pmid
  • 34339582
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.504
?:rankingScore_hIndex
  • 123
is ?:relation_isRelatedTo_publication of
?:title
  • A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all